Press Releases

Active Biotech AB Year-end Report January - December 2010
February 10, 2011 08:30 (CET)
Active Biotech successfully completes private placement of SEK 375 million
January 27, 2011 08:00 (CET)
Active Biotech announces launch of private placement of new shares
January 26, 2011 18:00 (CET)
Number of shares and votes in Active Biotech
December 30, 2010 08:30 (CET)
TEVA ANNOUNCES SUCCESSFUL RESULTS OF PHASE III STUDY WITH ORAL LAQUINIMOD FOR MULTIPLE SCLEROSIS
December 9, 2010 07:30 (CET)
Orphan Medicinal Product Status to Active Biotech's 57-57 project recommended
November 18, 2010 10:08 (CET)
Active Biotech's election committee appointed
November 3, 2010 14:00 (CET)
Number of shares and votes in Active Biotech
October 29, 2010 08:30 (CEST)
Active Biotech AB Interim Report January - September 2010
October 27, 2010 08:30 (CEST)
NEW DATA EVALUATING LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS DEMONSTRATE NEUROPROTECTIVE EFFECTS
October 15, 2010 15:30 (CEST)